Fetal Distress Clinical Trial
Official title:
The Effect of Maternal Long Term High Flow Oxygen Administration During Labor on Umbilical Cord Blood Gases
Verified date | August 2023 |
Source | Navy General Hospital, Beijing |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Supplementary oxygen is routinely administered to patients, even those with adequate oxygen saturations, in the belief that it increases oxygen delivery. However, oxygen delivery depends not just on arterial oxygen content but also on perfusion. Maternal oxygen administration has been used in an attempt to lessen fetal distress by increasing the available oxygen from the mother. However, the effect of supplemental maternal oxygen therapy on fetal acid base status has been debated for more than seven decades. The investigators found the use of 2 L/min maternal oxygen during the second stage of labor did not adversely affect either the umbilical artery pH value or the fetal heart rate (FHR) pattern distribution.
Status | Completed |
Enrollment | 140 |
Est. completion date | December 31, 2021 |
Est. primary completion date | October 31, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: at term (>37 weeks, <42 weeks), singleton, cephalic presentation, spontaneous or induced labor, normal labor, category I FHR tracings, 2 to 3 cm of cervical dilation in nulliparity, 1 to 2 cm of cervical dilation in multipara, informed consent. Exclusion Criteria: respiratory or cardiovascular disease, diabetes mellitus or insulin-treated gestational diabetes mellitus, hypertension or preeclampsia, oligohydramnios, fetal growth restriction, placental abruption, cephalopelvic disproportion, meconium-stained amniotic fluid, tachysystole, having received O2, uterine incision (myomectomy or perforation), anemia, fever, chorioamnionitis, tobacco or alcohol use, disorders in oxygen saturations, hypotension, uncomfortable with facemask. |
Country | Name | City | State |
---|---|---|---|
China | Department of Obstetrics and Gynecology, PLA Strategic Support Force Characteristic Medical Center | Beijing | |
China | Department of Obstetrics and Gynecology, Seventh Medical Center, Chinese PLA General Hospital | Beijing | |
China | Department of Obstetrics and Gynecology, Sixth Medical Center, Chinese PLA General Hospital | Beijing |
Lead Sponsor | Collaborator |
---|---|
Navy General Hospital, Beijing |
China,
Chuai F, Dong T, Liu Y, Jiang W, Zhang L, Chen L, Chuai Y, Zhou Y. The effect of intrapartum prolonged oxygen exposure on fetal metabolic status: secondary analysis from a randomized controlled trial. Front Endocrinol (Lausanne). 2023 Jun 27;14:1204956. doi: 10.3389/fendo.2023.1204956. eCollection 2023. — View Citation
Chuai Y, Jiang W, Zhang L, Chuai F, Sun X, Peng K, Gao J, Dong T, Chen L, Yao Y. Effect of long-duration oxygen vs room air during labor on umbilical cord venous partial pressure of oxygen: a randomized controlled trial. Am J Obstet Gynecol. 2022 Oct;227(4):629.e1-629.e16. doi: 10.1016/j.ajog.2022.05.028. Epub 2022 May 14. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Rate of cesarean delivery | at 1 minute after birth | ||
Other | Rate of assisted vaginal delivery | at 1 minute after birth | ||
Other | Apgar score less than 7 | The Apgar scale is determined by evaluating the newborn baby on five simple criteria on a scale from 0 to 2, then summing up the five values thus obtained. The resulting Apgar score ranges from 0 to 10. The five criteria are summarized using words chosen (Appearance, Pulse, Grimace, Activity, Respiration). The infant is given a score of 0, 1 or 2. The scores are added up and the total sum is their Apgar score.
The test is generally done at one and five minutes after birth, and may be repeated later if the score is and remains low. Scores 7 and above are generally normal, 4 to 6 fairly low, and 3 and below are generally regarded as critically low. |
at 1 and 5 minutes after birth | |
Other | Rate of serious neonatal morbidity or death | within 28 days of birth | ||
Other | Cord arterial plasma liquid chromatography mass spectrometry analysis | The systematic identification and quantitation of all the metabolic products (mainly endogenous small molecule compounds with relative molecular weight within 1000 Da) of cord arterial plasma under oxygen and room air conditions. Immediately after delivery (within 30-60 seconds of birth), blood plasma sample will be obtained. | within 30 to 60 seconds of birth | |
Primary | Cord arterial pH values | Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained. | within 30 to 60 seconds of birth | |
Primary | Cord arterial partial pressure of oxygen | Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained. | within 30 to 60 seconds of birth | |
Primary | Cord arterial partial pressure of carbon dioxide | Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained. | within 30 to 60 seconds of birth | |
Primary | Cord venous pH values | Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained. | within 30 to 60 seconds of birth | |
Primary | Cord venous partial pressure of oxygen | Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained. | within 30 to 60 seconds of birth | |
Primary | Cord venous partial pressure of carbon dioxide | Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained. | within 30 to 60 seconds of birth | |
Secondary | Rate of abnormal fetal heart tracing | at 1 minute after birth |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02221440 -
Maternal Oxygen Administration for Fetal Distress
|
N/A | |
Completed |
NCT04325243 -
Sildenafil Citrate and Intrapartum Fetal Distress
|
Phase 4 | |
Completed |
NCT03095937 -
Evaluation of Fetal Cardiac Function in Rheumatic Heart Disease (RHD) Patients
|
||
Completed |
NCT00185887 -
Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation
|
N/A | |
Completed |
NCT02862925 -
Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings.
|
N/A | |
Recruiting |
NCT06186973 -
Fetal Assessment of the Myocardium and Evaluation of the Neonate
|
||
Recruiting |
NCT05681624 -
Maternal Oxygen Supplementation for Intrauterine Resuscitation
|
N/A | |
Completed |
NCT05946681 -
Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
|
||
Completed |
NCT03536910 -
Evaluation of Copeptin Levels in Elective Cesarean Section With Different Anesthetic Technique
|
N/A | |
Completed |
NCT03156608 -
Novii External Fetal Monitoring Device
|
N/A | |
Recruiting |
NCT00246766 -
Study of Fetal Movements Using Multichannel Ultrasound Pulsed Doppler in Normal and Pathologic Pregnancy
|
N/A | |
Recruiting |
NCT04043299 -
Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes
|
Phase 3 | |
Not yet recruiting |
NCT03859037 -
Effect of Umbilical Cord Milking on Transition of Preterm Babies During Resuscitation
|
N/A | |
Completed |
NCT03370822 -
A Mixed Methods Study to Explore the Feasibility of a Novel Continuous Fetal Monitoring Device
|
||
Terminated |
NCT05147584 -
Trans-abdominal Fetal Pulse Oximetry
|
N/A | |
Not yet recruiting |
NCT05727241 -
Three-dimensional Umbilical Cord Coiling Index
|
||
Terminated |
NCT04081584 -
Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering
|
||
Completed |
NCT01042262 -
Maternal Oxygen Use During Delivery and Cord Blood Superoxide Dismutase
|
N/A | |
Not yet recruiting |
NCT04548453 -
Establish the uSI Values and End-user Training Material That Will be Used to Guide Oxytocin Dosing Actions
|
Early Phase 1 | |
Completed |
NCT03159234 -
Prediction of Fetal Lung Maturity
|
N/A |